Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 79.56K 73.31K 66.69K 125K 8.09M 131K 892K 355K 4.42M 328K 321K 13.87M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 224M 206M 188M 352M 22.76B 370M 2.51B 998M 12.43B 922M 903M 39.01B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.30%-6.68%+29.12%+125.42% 1,200B
+1.25%-5.35%+33.19%+80.42% 651B
+0.94%-2.99%+24.73%+106.93% 506B
-0.60%-1.95%+27.26%+67.32% 377B
+0.69%-9.50%+40.80%+30.23% 330B
+0.41%-4.70%+27.23%+51.59% 288B
+0.81%-4.08%-1.74%+32.71% 272B
-0.15%-6.45%+29.63%+64.18% 236B
-0.06%-0.98%+33.15%+118.99% 206B
Average +0.33%-4.28%+27.04%+75.31% 407B
Weighted average by Cap. +0.40%-5.19%+28.03%+87.49%

Financials

2016 2017
Net sales 54.27M 49.43M 45.55M 41.43M 77.72M 5.03B 81.69M 554M 220M 2.74B 204M 199M 8.61B 106M 96.5M 88.92M 80.88M 152M 9.81B 159M 1.08B 430M 5.36B 398M 389M 16.82B
Net income -103M -93.79M -86.42M -78.61M -147M -9.54B -155M -1.05B -418M -5.21B -386M -378M -16.35B -125M -114M -105M -95.58M -179M -11.59B -188M -1.28B -508M -6.33B -470M -460M -19.87B
Net Debt 209M 191M 176M 160M 300M 19.4B 315M 2.14B 850M 10.6B 786M 769M 33.25B 246M 224M 206M 188M 352M 22.75B 370M 2.51B 997M 12.42B 922M 902M 38.99B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock